Terjemahan ini sedang disediakan. Buat sementara, kami memaparkan versi asal dalam bahasa Inggeris.
Pemula · 27/10/20261 min read
Orphan Therapeutics Accelerator In-Licenses Investigational Gene Therapy Program for Ornithine Transcarbamylase Deficiency from UCL Ventures and Children's Medical Research Institute
Terjemahan automatik tempatan · Bahasa asal sumber
Ringkasan
OTXL-101, a promising therapy in development for a severe, rare pediatric metabolic condition, becomes the first pipeline program to be in-licensed by Orphan Therapeutics Accelerator (OTXL) CAMBRIDGE, Mass., Oct. 27,…
Bahasa asal sumber: PR Newswire UK — News ReleasesBuka kenyataan asal →